Neotherix is part of a collaboration awarded a £50k Regenerative Medicine Technology Validation grant by regeNer8. The project (which has an overall value of £100k) is one of four funded in this round, and is a continuation of our previous successful Proof of Concept collaborative studies with the Leeds Dental Institute, University of Leeds and the Institute of Pharmaceutical Innovation, University of Bradford (see earlier news article).

The aim is to combine three technologies using a novel scaffold, a new antimicrobial technique and, optionally, stem cells to provide an innovative approach for regenerative medicine which minimises the risk of infection. Work will focus on further synthesis of bioresorbable polymeric scaffolds containing antibacterial agents that can be activated in response to specific external stimuli. This allows targeted bacterial control without compromising the viability of cells in the surrounding normal or grafted tissue or of cells delivered via the scaffold. The results from this project will be enable us to move closer to the market for the application of tissue engineering techniques and stem cell therapy in regenerative medicine for the repair and restoration of diseased, damaged and excised tissues.

Links to the regeNer8 press release , Leeds Dental Institute and Institute of Pharmaceutical Innovation, University of Bradford